|Articles|September 2, 2021
Supplements and Featured Publications
- Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape
- Volume 27
- Issue 15
Participating Faculty for Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape
Advertisement
FACULTY
Curry L. Koening, MD, MS
Division of Rheumatology
University of Utah and George E. Wahlen Department of Veterans Affairs Medical Center
Salt Lake City, UT
Irene von Hennigs, PharmD
Vice President, Medical Affairs
ChemoCentryx, Inc
San Carlos, CA
FACULTY DISCLOSURES
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Curry L. Koening, MD, MS
CONSULTANCIES OR PAID ADVISORY BOARDS
ChemoCentryx, Inc
Irene von Hennigs, PharmD
CONSULTANCIES OR PAID ADVISORY BOARDS
ChemoCentryx, Inc
EMPLOYMENT
ChemoCentryx, Inc
STOCK OWNERSHIP
ChemoCentryx, Inc
INSITUTIONAL CONFLICTS OF INTEREST
ChemoCentryx, Inc
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Bringing CAR T-Cell Therapy Into Community Cancer Centers
2
The True Cost of Running a Community CAR T-Cell Program
3
Texas Hospitals Lose $27 Million a Day in Medicaid Funding Dispute
4
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
5
